Test BackgroundTheophylline is primarily a bronchial dilator, indicated in the treatment of reversible airways obstruction, such as COPD and severe acute asthma.
Clinical Indications Therapeutic drug monitoring Assessment of toxicity: symptoms include tachycardia, palpitation, nausea and other gastrointestinal disturbances, headache, CNS stimulation, insomnia, arrhythmias and convulsions, especially if given rapidly by intravenous injection
|:|| 0 - 6 Months of 6-11 mg/L
Sample Required SST (gold top)
Sample Volume 0.5 mL
Turnaround Time 1 day